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Functional disruption of dendritic cells (DCs) is an important strategy for viral pathogens to
evade host defences. Monocytotropic viruses such as classical swine fever virus (CSFV) could
employ such a mechanism, since the virus can suppress immune responses and induce apoptosis
without infecting lymphocytes. Here, CSFV was shown to infect and efficiently replicate in
monocyte- and in bone marrow-derived DCs. Interestingly, the infected DCs displayed neither
modulated MHC nor CD80/86 expression. Stimulation of DCs with IFN-a/TNF-a or
polyinosinic–polycytidylic acid (pIC) induced phenotypic maturation with increased MHC and
CD80/86 expression, both with mock-treated and infected DCs. In addition, the T cell stimulatory
capacity of CSFV-infected DCs was maintained both in a polyclonal T cell stimulation and in
specific antigen-presentation assays, requiring antigen uptake and processing. Interestingly, similar
to macrophages, CSFV did not induce IFN-a responses in these DCs and even suppressed
pIC-induced IFN-a induction. Other cytokines including interleukin (IL)-6, IL-10, IL-12 and TNF-a
were not modulated. Taken together, these results demonstrated that CSFV can replicate in DCs
and control IFN type I responses, without interfering with the immune reactivity. These results are
interesting considering that DC infection with RNA viruses usually results in DC activation.
INTRODUCTION
Classical swine fever (CSF) is a highly contagious disease
of pigs caused by CSF virus (CSFV) and leads to important
economic losses worldwide. CSFV together with bovine viral
diarrhoea virus (BVDV) and border disease virus (BDV)
form the genus Pestivirus within the family Flaviviridae.
CSFV is a monocytotropic viral pathogen, which can
efficiently evade and compromise the host’s immune
system. The virus has a high affinity for reticulo-endothelial
cells (Cheville & Mengeling, 1969; Ressang, 1973; Susa et al.,
1992) causing lymphopenia, thrombocytopenia, coagula-
tion disorders and atrophy of the thymus and bone marrow
(Gomez-Villamandos et al., 2003; Pauly et al., 1998;
Sanchez-Cordon et al., 2002; Summerfield et al., 2000,
2001). Lymphopenia is caused, at least in part, by apoptosis
detectable in uninfected lymphocytes (Sanchez-Cordon
et al., 2003; Summerfield et al., 1998b). In addition, viable
lymphocytes isolated from CSFV-infected pigs do not
respond to mitogen stimulation (Pauly et al., 1998;
Summerfield et al., 1998b; Van Oirschot et al., 1983).
These modulated cells are not infected. Instead, it is the
myeloid population, particularly monocytes (Mo) and
macrophages (Mw), that contains the early target cell for
infection and replication, both in vivo (Ressang, 1973;
Gomez-Villamandos et al., 2001; Sanchez-Cordon et al.,
2003; Summerfield et al., 2000; Trautwein, 1988) and in vitro
(Knoetig et al., 1999). Despite this clear targeting and
tropism, no direct evidence has been found of a role for
infected Mo and Mw in the observed immunosuppression
and death of T lymphocytes (Knoetig et al., 1999).
Dendritic cells (DCs) are one of the primary immunological
sentinels of the immune system (Banchereau et al., 2000;
Steinman, 1991). They can efficiently sense invading
pathogens by a set of pattern recognition receptors. Their
strategic localization at the site of pathogen entry – mucosal
surfaces and dermal layers – makes them a particularly early
target for virus contact (MacPherson & Liu, 1999). After
detection, uptake and degradative processing of the virus,
DCs should mature and subsequently promote effective
immune responses by migrating into lymphoid tissue to
present the processed viral antigens to T lymphocytes
(Pulendran et al., 2001).
Interestingly, certain viruses are tropic for DCs.
Human immunodeficiency virus, measles virus (MV),
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cytomegalovirus and herpes simplex virus type 1 infect, sur-
vive and even replicate in these potent antigen-presenting
cells, inducing immunosuppression, mediated in part
through the infected DCs (Klagge & Schneider-Schaulies,
1999). A problem for the virus could arise if the infection
results in activation of receptors for double-stranded
(ds)RNA such as toll-like receptor 3 and protein kinase R,
which would activate and mature the DCs. Such an
observation has been made particularly with certain DC-
tropic RNA viruses including MV (Fugier-Vivier et al.,
1997), influenza virus (Cella et al., 1999), Semliki Forest
virus (Johnston et al., 1996), dengue virus (Ho et al., 2001)
and Sindbis virus adapted to human DCs (Gardner et al.,
2000). As a consequence, type I IFN production is induced
and the virus-infected DCsmature to acquire the capacity to
induce potent MHC class I- and II-restricted antiviral
immune responses. In the context of CSFV, the results with
dengue virus, also a member of the Flaviviridae, are
interesting, yet nothing is known about the interaction of
CSFV with DCs.
Considering these fundamental elements in virus–host
interactions, particularly of monocytotropic viruses, the
objective of the present study was to determine the affinity of
CSFV for DCs and the functional consequences of that
infection.
METHODS
Media and reagents. DCs were cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen) supplemented with 2 mM glu-
tamine, 100 U penicillin ml21, 100 mg streptomycin ml21 and
50 mM 2-ME (all from Invitrogen). Serum supplements for DC
cultures employed 10% (v/v) porcine serum (Sigma Chemicals).
Recombinant porcine (rp) cytokines utilized for DC generation were
as follows: rpGM-CSF (kindly provided by Dr S. Inumaru, Institute
for Animal Health, Ibaraki, Japan; Inumaru et al., 1998) and
rpTNF-a (kindly provided by Dr G. Bertoni, Institute of Veterinary
Virology, Berne, Switzerland; Von Niederhausern et al., 1993).
Recombinant porcine IL-4 was prepared in our laboratory, as
described previously (Carrasco et al., 2001). MHC class I was
detected with mAb 74-11-10 (Pescovitz et al., 1984) (kindly donated
by Dr J. K. Lunney, USDA, Beltsville, USA) and MHC class II with
mAb MSA3 (Hammerberg & Schurig, 1986) (from VMRD, Pullman,
WA, USA). CD80/86 expression was measured using a huCTLA4–
mouse Ig fusion protein (Alexis, Lausen, Switzerland).
Generation of porcine DCs. Bone marrow (BM)-derived and
blood Mo-derived DCs were generated as described previously
(Carrasco et al., 2001). Briefly, low-density bone marrow haemato-
poietic cells (BMHCs) and PBMCs were obtained by density-
gradient centrifugation over Ficoll-Paque (1?077 g l21; Amersham
Pharmacia Biotech). BM-DCs were generated from BMHCs using
rpGM-CSF (25 ng ml21) and rpTNF-a (30 U ml21), cultured for
8 days at 39 uC. At days 3 and 6, the BM-DC culture was fed with
the cytokines. Mo-DCs were generated from blood Mo isolated by
plastic adherence, using rpGM-CSF (150 ng ml21) and rpIL-4
(100 U ml21), cultured for 7 days at 39 uC. At days 2, 4 and 6, the
Mo-DC culture was fed with the cytokines. Maturation of DCs was
induced by treatment with a cocktail of recombinant porcine IFN-a
(1000 U ml21; R&D Systems) and TNF-a (10 ng ml21; Endogen)
for 48 h. Alternatively, maturation was induced with polyinosinic–
polycytidylic acid (pIC; Sigma) transfection to mimic a virus
infection. DCs were washed twice with serum-free DMEM at 37 uC
and resuspended at a concentration of 46106 cells ml21 in 500 ml
Opti-MEM (Invitrogen). pIC was first incubated for 30 min with
2 ml of a single-stranded RNA-specific RNase cocktail composed of
500 U RNase A ml21 and 20 000 U RNase T1 ml21 (both from
Ambion) in 100 ml at 37 uC. This digestion improved the stimulatory
activity of pIC for DCs, whereas treatment with dsRNA-specific
RNase abolished the capacity of pIC to induce DC maturation
(M. Ceppi, unpublished results). This mixture was allowed to form
complexes with 24 ml TransFast (Promega) in 500 ml Opti-MEM for
15 min at room temperature, before adding to the DCs and incubat-
ing for 1 h at 39 uC. After lipofection, cells were washed twice with
serum-free DMEM at 37 uC before use in T cell stimulation assays.
CSFV infection. The virulent Brescia strain (Summerfield et al.,
1998b) was used if not otherwise indicated. For certain other experi-
ments, the virulent Eystrup strain (Mayer et al., 2003), the moder-
ately virulent Alfort/187 strain (Ruggli et al., 1996) and the avirulent
C-strain (vflc2 corresponding to Flc 133 described by Moormann
et al., 1996) were employed. These viruses and mock controls were
prepared in swine kidney SK-6 cells as described (Knoetig et al.,
1999). In some experiments, UV-inactivated virus and preparations
(Knoetig et al., 1999) were used as additional controls. DCs
(BMHCs or Mo) were mock-treated or infected with CSFV at the
m.o.i.s specified in the results. The presence of viral antigen in the
DCs was quantified by immunofluorescent analysis using micro-
scopic or flow cytometric detection of the viral E2 structural glyco-
protein with mAb HC/TC26 (kindly provided by Dr Bommeli,
Diagnostics AG, Berne, Switzerland; Greiser-Wilke et al., 1990). The
viral non-structural NS3 protein was detected with mAb C16
(kindly provided by Dr I. Greiser-Wilke, Hannover Veterinary
School, Germany; Greiser-Wilke et al., 1992). Due to the internal
expression of E2 and NS3, the DCs were fixed and permeabilized
(Cell Permeabilization Kit; Harlan Sera-Lab) before labelling with
the mAbs.
Analysis of CSFV replication in BM- and Mo-DCs was assessed by
incubating the non-adherent DCs with CSFV at an m.o.i. of 10 TCID50
per cell for 1 h at 39 uC. The cells were then washed a total of ten times
by centrifugation. Cell-associated virus (CAV) from these DCs was
obtained by two cycles of freeze–thawing of the cell pellets, which were
then clarified by centrifugation at 10 000 g for 20 min and resuspended
to the original culture volume. The measurement of virus titres from
extracellular virus (ECV) and CAV were quantified by end-point
titration on PK-15 cells and immunofluorescent detection.
DC-dependent T lymphocyte stimulation assays. T cell purifi-
cation for all assays (SEB-, FMDV- and CSFV-dependent) used
MACS (magnetic activated cell sorting), wherein either CD6+ T cell
enrichment or SWC3+ Mo depletion was used. T cells were cultured
at 26105 cells per well. The microbial superantigen staphylococcal
enterotoxin B (SEB) (Toxin Technology) was used to measure the
potency of DCs at inducing T cell responses dependent on MHC
class II–T cell receptor cross-linking (Bhardwaj et al., 1992). BM-
DCs were incubated simultaneously with mitomycin C (10 mg ml21)
and SEB (100 ng ml21) for 1 h at 39 uC, washed four times and
titrated in a 96-well flat bottom microtitre plate as described. After
2 days, 1 mCi (37 kBq) [3H]thymidine was added for another 18 h to
quantify proliferation.
The processing and presentation of antigen was assessed in two
antigen-specific assays. For the CSFV-specific antigen-presentation
assays, PBMCs for both Mo-DC generation and lymphocyte isolation
were obtained from pigs 4–8 months after infection with CSFV
Alfort187 (Ruggli et al., 1996). CSFV was added to the DC/lymphocyte
co-cultures at an m.o.i. of 0?01 TCID50 per cell. The foot-and-mouth
disease virus (FMDV)-specific restimulation assay employed T cells
and Mo-DCs isolated from pigs vaccinated against FMDV (three
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booster injections, serotype C1 Oberbayern; vaccine kindly provided by
Dr P. Barnett, Institute for Animal Health, Pirbright, UK). The DCs
and T cells were co-cultured in the presence of b-propiolactone-
inactivated FMDV antigen as described previously (Carrasco et al.,
2001). After 4 days for the FMDV and 5 days for the CSFV resti-
mulation, 1 mCi [3H]thymidine was added for another 18 h to quantify
proliferation. T cell activation was only observed with immune
animals.
Cell viability and apoptosis analysis. For quantification of
apoptotic cells expressing phosphatidylserine on their surface and
dead cells permeable to propidium iodide (PI; Sigma), dual para-
meter analysis of AnnexinV-FITC (Bender Med Systems) and PI
were performed (Vermes et al., 1995). To this end, 56105 cells were
labelled with 2 mg AnnexinV-FITC ml21 in 140 mM NaCl, 2?5 mM
CaCl2, 10 mM HEPES (pH 7?4) buffer for 10 min. After FL1/FL2
compensation, PI (100 ng ml21) was added, to discriminate between
apoptotic and dead cells and the sample analysed by flow cytometry.
Cytokine responses. Cytokines produced by DCs were induced
with either pIC or lipopolysaccharide (LPS, Escherichia coli-derived;
Sigma). The concentration of secreted IFN type I in the supernatants
was quantified using a bioassay based on the antiviral effect of IFN
type I against vesicular stomatitis virus (VSV). Reduction of VSV-
induced cytopathic effect in PK-15 cells induced by the test samples
or by recombinant porcine IFN-a (R&D Systems) as a standard was
quantified as described previously (Ruggli et al., 2003). The presence
of IFN-a was controlled by addition of a neutralizing anti-porcine
IFN-a polyclonal antiserum (R&D Systems).
Other cytokines produced by DCs were measured using commercially
available ELISAs designed for porcine IL-6, IL-10, IFN-c (Biosource)
and TNF-a (Perbio Science).
For quantification of IL-10 and IL-12 mRNA levels, RNA was isolated
from DCs using the RNeasy Kit (Qiagen). This RNA was reverse-
transcribed to cDNA using the Omniscript RT Kit (Qiagen). The
cDNA levels of cyclophilin (housekeeping gene), IL-10 and IL-12
(subunits p35 and p40) were quantified on the Icycler IQ Multicolour
Real-Time PCR Detection System (Bio-Rad) using the Lightcycler
Faststart DNAMaster SYBR Green kit (Roche Molecular Diagnostics).
Duplicate samples as well as serial dilutions of each target amplicon
were analysed using the following optimized protocol. A 10 min
incubation at 95 uC was employed to activate the polymerase and
denature the targets. This was followed by 50 cycles of 30 s at 95 uC,
30 s at 55 uC (cyclophilin), 59 uC (IL-10, IL-12p40) or 61 uC (IL-
12p35), and 30 s at 72 uC. After a final extension for 10 min at 72 uC,
the programme was ended with a melt curve programme. All reactions
were performed in 20 ml (1 ml sample added), theMgCl2 concentration
was 3 mM in all cases and the primer concentrations were 0?25 mM.
The following forward and reverse primers, respectively, were used for
PCR: cyclophilin: 59-TAACCCCACCGTCTTCTT-39 and 59-TGCCA-
TCCAACCACTCAG-39; IL-10: 59-GCATCCACTTCCCAACCA-39
and 59-CTTCCTCATCTTCATCGTCAT-39; IL-12p35: 59-GCCTCAA-
CCACTCCCAAAATC-39 and 59-CTTCCAGGGAGGGCTTCTGT-39;
and IL-12p40: 59-GCAAAACCCTGACCATCCAC-39 and 59-TGCC-
CTCCTGACACTCCACT-39. Serial dilutions were used to generate
standard curves from which the concentration of each sample was
deduced. All cytokine data were normalized to the expression of
cyclophilin.
RESULTS
CSFV infection of DCs
It is known that CSFV has an affinity for myeloid cells
(Knoetig et al., 1999; Ressang, 1973; Summerfield et al.,
1998a, b, 2000, 2001). However, there is no information on
the susceptibility of DCs to CSFV infection. Considering the
central role that DCs play in the stimulation and control of
immune defence development, this is a subject of particular
importance. As a cell culture model, Mo- and BM-DCs, both
representing myeloid DCs, were used. Similar to other
species, these cells are characterized as DCs based on their
dendritic morphology, non-adherence, their potent T cell
stimulatory capacity and their expression of CD1, CD80/86
and MHC class II (Carrasco et al., 2001). Consequently,
BM- or Mo-DCs were infected with CSFV at an m.o.i. of 1
TCID50 per cell. At 48 h post-infection, the majority of the
infected BM- and Mo-DCs were seen to express viral E2 and
NS3 proteins (Fig. 1). The detection method for these viral
proteins did not permit the detection of virus entry, but only
de novo protein synthesis (Knoetig et al., 1999). These results
suggested a productive infection of the DCs, which was
confirmed by the observation of a 3–4 log10-fold increase
in the virus titres of ECV and CAV between 24 and 72 h
post-infection (Fig. 2). Interestingly, the CAV titres were
invariably lower than the ECV titres, contrasting with
infected SK-6 cells, where the majority of de novo-
synthesized virus was cell-associated (data not shown).
Similar elevated ECV titres compared with CAV titres have
been observed with CSFV-infected Mo (S. M. Knoetig and
A. Summerfield, unpublished data).
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Fig. 1. Viral protein expression in BM-DCs and Mo-DCs at
48 h after CSFV infection at an m.o.i. of 1 TCID50 per cell.
(a) Structural glycoprotein E2 expression. (b) Non-structural
protein NS3 expression. The filled histograms represent the
staining of mock-treated cells used to determine the non-
specific staining. Data shown in (a) and (b) are representative
of 11 independent experiments.
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DC morphology and maturation after CSFV
infection
No morphological difference between CSFV-infected and
mock-treated DCs was noted (data not shown). This corre-
lated with the observation that CSFV is non-cytopathic for
Mo and Mw (Knoetig et al., 1999). In addition, CSFV
infection of DCs had no apparent influence on their
‘maturation status’ with respect to the expression of MHC
class I, II and CD80/86 (Fig. 3). CD80/86 was already
expressed without addition of maturation signals, but could
be induced to be further upregulated by in vitro stimulation.
This is characteristic of porcine Mo-DCs (Carrasco et al.,
2001) and also porcine blood DCs (Summerfield et al.,
2003). Consequently, it was investigated whether CSFV-
infected DCs were altered in their response to maturation
signals. When CSFV-infected or mock-treated DCs were
stimulated either with a TNF-a/IFN-a cocktail or with pIC,
upregulation of molecules involved in antigen presentation,
typical of DC maturation, was observed in both mock-
treated and CSFV-infected DCs (Fig. 3 shows the results for
the IFN-a/TNF-a-induced maturation). The observation
that CSFV did not influence the expression of maturation
markers such as CD80/86 was also observed with other
strains of CSFV, including the avirulent C-strain, the
moderately virulent Alfort strain and the virulent Eystrup
and Brescia strains. In addition, no modulation was
observed using UV-inactivated virus as an additional
control (Fig. 3b).
Functional activity of DCs infected with CSFV
Having observed efficient CSFV replication in DCs with-
out detectable alteration in cell morphology or consistent
modulation of MHC and CD80/86 expression, the influ-
ence of infection on the functional activity of the DCs
was assessed. To this end, DCs were pulsed either with
the microbial superantigen SEB or with viral antigens,
and their capacity to stimulate proliferative T cell responses
was quantified. Although CSFV-infected DCs were seen
to be more stimulatory for SEB-induced T cell prolifera-
tion compared with mock-treated DCs (Fig. 4), the dif-
ference was not always reproducible. A statistical analysis
(Student’s t-test) of 11 SEB-dependent proliferation assays
demonstrated no significant differences between mock-
treated and CSFV-infected DCs in this functional test
(P=0?2).
When the same experiments were performed with IFN-a/
TNF-a-stimulated infected or mock-treated DCs, it was
often observed that the CSFV-infected cells promoted a
higher lymphoproliferation compared with the mock con-
trols (Fig. 4a). Nevertheless, this observation was also not
seen in all experiments and a statistical analysis of the results
indicated no significant difference (P=0?23). When the
DCs were stimulated with lipofected pIC as the maturation
signal, both the mock-treated and the CSFV-infected DCs
upregulated their capacity to stimulate T cell proliferation to
a similar degree (Fig. 4b).
To investigate further any possible functional modulation of
CSFV-infected DCs, the influence of virus infection on an
MHC-restricted antigen-specific T cell response, which
requires antigen uptake, processing and presentation, was
tested. CSFV-infected DCs were able to stimulate T cell
proliferation in an FMDV-specific antigen-presentation
assay and this was of a similar intensity to that obtained with
mock-treated Mo-DCs (Fig. 5a). Another important obser-
vation was that IFN-c protein levels were not altered when
supernatants from T lymphocytes activated bymock-treated
or CSFV-infected DCs presenting FMDV antigen were
analysed (Fig. 5b). This indicated that CSFV did not shift
the T cell response towards a Th1 or a Th2 pattern. Finally,
CSFV-infected DCs could also restimulate CSFV-specific
T cell proliferation (Fig. 5c). Taken together, these results
demonstrated that CSFV-infected DCs were certainly
functionally intact with respect to their capacity to induce
T cell activation.
Cell viability following CSFV infection
In the acute phase of severe CSF, death of uninfected
lymphocytes can be detected in the animals. Consequently,
even though CSFV was not apparently cytopathic for DCs
in terms of morphological changes, it was necessary to
determine whether an augmented rate of cell death was
present in the infected DC/lymphocyte co-cultures. Using
lymphocyte co-cultures with DCs at a ratio of 10 : 1, viability
analysis at 24, 48 and 72 h showed no significant difference
in the number of AnnexinV-positive and PI-positive cells
between mock controls and CSFV-infected cultures (data
not shown).
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Fig. 2. Replication kinetics of CSFV in BM-DCs (a) and Mo-
DCs (b), infected at an m.o.i. of 10 TCID50 per cell for 1 h at
39 6C. At the indicated time points, the culture supernatant
medium was harvested for ECV and the cells for CAV, as
described in Methods. Data shown in (a) and (b) are represen-
tative of three independent experiments.
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Cytokine responses
In a final series of analyses, the capacity of CSFV tomodulate
the cytokine response of virus-infected DCs was character-
ized. Similar to infection of Mo and Mw (Knoetig et al.,
1999; Ruggli et al., 2003), CSFV did not induce type I IFN
responses in Mo-DCs. On the contrary, CSFV-infected DCs
had a defective type I IFN response to pIC stimulation
(Table 1). As for other cytokines, the protein levels of IL-6,
IL-10 and TNF-a measured by ELISA, as well as the mRNA
levels of IL-10 and IL-12 (p35 and p40), were not modulated
by CSFV infection (Table 1). No modulation of sponta-
neously induced TNF-a, IL-6 or IL-10 protein was
detectable. The same was found for IL-10 and IL-12
p40 mRNA levels (Table 1). IL-12 p35 mRNA was not
detectable in mock- or in CSFV-infected DCs (data not
shown). Furthermore, the induction of TNF-a by LPS and of
IL-6 by LPS and pIC were not modified by CSFV (Table 1).
DISCUSSION
CSFV is a haemorrhagic and immunosuppressive viral
pathogen that has been seen in histological sections
associated with dendritic-like cells (Susa et al., 1992).
Non-infected T lymphocytes from animals with CSF do not
respond to antigen or mitogen stimulation and rapidly
undergo apoptosis in vivo and after ex vivo culture. Yet,
CSFV is well documented as being non-cytopathogenic.
Furthermore, in vitro infection of Mo or Mw with this
monocytotropic virus did not induce detectable lymphocyte
immunosuppression nor was apoptosis discernible (Knoetig
et al., 1999). This would indicate that infected Mw are not
directly responsible for the reported lymphocyte death and
anergy in CSF (Pauly et al., 1998; Van Oirschot et al., 1983).
Consequently, the present work sought to determine
whether DCs, the major myeloid cell type interacting with
lymphocytes, are involved in CSFV immunopathogenesis.
CSFV was seen to be highly efficient at infecting and
productively replicating in DCs, both Mo-DCs and BM-
DCs. These observations that CSFV is tropic for DCs
indicated that these critically important promoters and
Fig. 3. CD80/86, MHC class I and MHC class II expression
on Mo-DCs after infection with CSFV. (a) The cells were mock-
treated (light-line histograms) or infected with CSFV (dark-line
histograms) at an m.o.i. of 1 TCID50 per cell and cultured for
48 h. DC maturation was induced with IFN-a/TNF-a for another
48 h in some cultures as indicated. The dotted-line histograms
represent the conjugate controls. For each histogram plot, the
geometric mean fluorescence intensity (MFI) for the mock con-
trols and the virus-infected DCs is indicated. The data shown
are representative of five independent experiments. (b) Influence
of various CSFV strains and UV-inactivated virus on CD80/86
expression. The geometric means determined as described in
(a) for unstimulated DCs (white bars) and for IFN-a/TNF-a-
stimulated DCs (grey bars) are shown. Experimental conditions
were as described in (a).
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Fig. 4. Antigen-presentation capacity of CSFV-infected DCs, influenced by maturation signals. Mo-DCs were mock-treated
(m, n) or CSFV-infected (m.o.i. of 1 TCID50 per cell; $, #) for 48 h. Some cultures were further stimulated (filled symbols)
with either IFN-a/TNF-a for 48 h (a) or pIC (transfection) for 24 h (b). The capacity of the Mo-DCs to present cell-bound SEB
to T lymphocytes and to induce T cell proliferation at different DC : lymphocyte ratios is shown. Data shown are representative
of 11 experiments, displaying the mean±SD of triplicate values.
Fig. 5. Capacity of CSFV-infected DCs to process and present antigen. Mo-DCs were exposed to mock (m, n) or CSFV
(m.o.i. of 1 TCID50 per cell; $, #) for 48 h. For (a) and (b), these DCs were then incubated with FMDV antigen (filled
symbols) or mock BHK-cell antigen (open symbols) for another 24 h, before co-culturing with autologous T lymphocytes from
an FMDV-immune animal. The T cell responses were measured in a proliferation test (a) and by quantification of IFN-c protein
in supernatants after 48 h co-culture (b). The data shown are representative of four (a) or two (b) independent experiments.
(c) The CSFV-infected DCs ($) or mock-treated controls (m) were co-cultured with autologous T lymphocytes from a
CSFV-immune animal. The antigen specificity of these responses was controlled by performing the same experiments with
non-immune animals (data not shown). DCs were titrated to obtain different DC : T lymphocyte ratios and the mean±SD of
triplicate c.p.m. values are displayed.
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controllers of immune response development would serve
as a main target cell for CSFV replication. Considering the
non-cytopathogenic nature of CSFV and the migratory
characteristics of DCs, infected DCs would present a
reservoir for the efficient dissemination of the virus. The
latter aspect is particularly important due to the trafficking
of DCs from peripheral sites, such as the mucosal surfaces
at which CSFV would invade the host, to the secondary
lymphoid tissue where close contact to lymphocytes could
have detrimental consequences.
Despite this tropism of CSFV for DCs, there was no clear
morphological, phenotypic or functional modulation. This
contrasts with dengue virus, another flavivirus, which
induced DC maturation (Ho et al., 2001; Libraty et al.,
2001; Wu et al., 2000). It has been reported that DCs can
be activated through dsRNA-dependent stimulation (Cella
et al., 1999). Considering the fact that many RNA viruses
forming dsRNA intermediates during their replicative cycle
activate DCs (for example, see Introduction), it would
appear that CSFV has developed mechanisms to control or
limit DC activation. Both the non-cytopathogenic and the
cytopathogenic biotypes of another pestivirus, BVDV, do
not activate DCs (Glew et al., 2003), suggesting that such
common means for evading immune recognition may be a
characteristic of all pestiviruses. This would relate to their
capacity to interfere with pIC-induced IFN responses in Mw
(Ruggli et al., 2003; Schweizer & Peterhans, 2001). Indeed,
CSFV impairs pIC-induction of type I IFN in DCs and the
recent report of Glew et al. (2003) has shown a similar effect
of BVDV in bovine DCs. However, the current analyses
demonstrating that the response of CSFV-infected DCs
to maturation signals for DCs – including pIC – was not
impaired contrasted with this effect on type I IFN induci-
bility. It would therefore appear that the DC maturation
induced by pIC was IFN-independent. In fact, the indepen-
dence of virus-induced DC maturation from secreted IFN-a
has been reported recently (Lopez et al., 2003).
Considering this inability of CSFV to interfere with
DC maturation, the question arose concerning the func-
tionality of the DCs as antigen-presenting cells. Using
antigen-presentation assays for polyclonal SEB stimulation,
as well as FMDV- and CSFV-specific restimulation assays, it
was observed that CSFV did not impair the capacity of DCs
to process and present antigens. The recent report of Glew
et al. (2003) has also shown that BVDV-infected bovine DCs
retained their capacity to function as antigen-presenting
cells. With the CSFV infections in the present report, it was
particularly interesting to note that the infected DCs could
still present CSFV antigen and stimulate CSFV-specific
lymphocyte responses. Furthermore, apart from suppressed
IFN type I responses, the cytokine profile of the DCs was
not modified. For the interpretation of these results and
particularly the cytokine responses, it is important to note
that in vitro-derived DCs represent a cell culture model for
myeloid DCs, which does not reflect the complexity of the
DC system. Consequently, further studies investigating the
interaction of CSFV with, for instance, plasmacytoid DCs
are required in the future.
The interaction of CSFV with DCs can be seen as a double-
edged sword. On one side, CSFV has developed a mechan-
ism to prevent antiviral responses, permitting the virus to
replicate in DCs and to use these highly migrating cells as a
‘taxi’ for transport to different sites in the host body. This
would enable virus ‘delivery’ to lymphoid tissue, where it is
know that considerable lymphocyte destruction occurs
during CSF. The simple interaction between CSFV-infected
DCs and lymphocytes is inadequate for the induction of
such cell death. It would therefore appear that the environ-
ment particular to lymphoid follicles has a major role to
play. On the other side, the present report demonstrates that
CSFV-infected DCs do remain functional and are able to
induce T cell responses against the virus.
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Table 1. Cytokine responses of CSFV-infected DCs
IFN I (U ml”1) TNF-a (pg ml”1) IL-6 (pg ml”1) IL-10 IL-12 p40
pg ml”1 mRNA* mRNA*
Mock 2 11±1 166±4 24±1?2 0?5±0?1 0?1±0?01
CSFV 2 19±2 220±5 43±2?3 0?9±0?3 0?2±0?01
Mock LPS 2 431±23 2365±59 ND ND ND
CSFV LPS 2 480±13 1720±31 ND ND ND
Mock pIC 14±2 ND 2373±57 ND ND ND
CSFV pIC 0?5±0?2 ND 2237±43 ND ND ND
*mRNA molecules, cytokine/cyclophilin.
2, Not detectable; ND, not determined.
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